• United-Guardian posted Q2 net sales up 10% to USD 3.11 million; net income rose 16% to USD 728,579.
• Diluted EPS increased to USD 0.16 from USD 0.14.
• First-half net sales climbed 12% to USD 5.98 million; net income jumped 30% to USD 1.55 million.
• Cosmetic ingredient sales rose 44% in Q2 and 34% in the first half, driven by higher purchases from Ashland Specialty Ingredients.
• Pharmaceutical sales increased 1% in Q2 and 11% in the first half, led by Renacidin; the company highlighted expanded promotion plans for Renacidin and “natural” products.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United-Guardian Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608071030PRIMZONEFULLFEED9805982) on August 07, 2026, and is solely responsible for the information contained therein.